SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-22-000044
Filing Date
2022-05-11
Accepted
2022-05-11 16:50:15
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20220331.htm   iXBRL 10-Q 808897
2 EX-31.1 sum-ex311_20220331x10q1.htm EX-31.1 11829
3 EX-32.1 sum-ex321_20220331x10q.htm EX-32.1 6854
  Complete submission text file 0001599298-22-000044.txt   4244778

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20220331.xsd EX-101.SCH 37736
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20220331_cal.xml EX-101.CAL 42992
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20220331_def.xml EX-101.DEF 128636
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20220331_lab.xml EX-101.LAB 407095
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20220331_pre.xml EX-101.PRE 279641
57 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20220331_htm.xml XML 564684
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 22914471
SIC: 2834 Pharmaceutical Preparations